Inventor · disambiguated record
Anne Marinier
Also filed as: MARINIER ANNE
22 granted patents·4 pending applications·164 citations·filing 1996–2023
94Inventor score
Top patents by PatentIndex Score
26 records- 0193US7223757B2Tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 29, 2007·16 cites·21 claims
- 0289US9429566B2Assay for inhibitors of CIP/KIP protein degradationUNIV MONTREAL·Filed 2012·Granted Aug 30, 2016·11 cites·20 claims
- 0388US6414179B1Alpha-and beta-substituted trifluoromethyl ketones as phospholipase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 2, 2002·32 cites·9 claims
- 0486US9518064B2Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 13, 2016·5 cites·18 claims
- 0582US5747463AMalonate derivatives of glycolipids as cell adhesion inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1996·Granted May 5, 1998·62 cites·20 claims
- 0674US12286426B2Heterocyclic mitochondrial activity inhibitors and uses thereofUNIV MONTREAL·Filed 2023·Granted Apr 29, 2025·0 cites·19 claims
- 0774US7081454B2Tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 25, 2006·6 cites·20 claims
- 0874US6933294B2Thiophene-based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 23, 2005·10 cites·19 claims
- 0974US6825233B2Compounds having retinoid-like activityBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 30, 2004·7 cites·7 claims
- 1072US6319948B2Retinoid antagonists and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Nov 20, 2001·4 cites·8 claims
- 1172US2023338429A1Compounds and use thereof in the expansion of stem cells and/or progenitor cellsUNIV MONTREAL·Filed 2023·Application pending·0 cites
- 1270US8343999B2Thiazolyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jan 1, 2013·1 cites·4 claims
- 1365US11760754B2Heterocyclic mitochondrial activity inhibitors and uses thereofUNIV MONTREAL·Filed 2018·Granted Sep 19, 2023·0 cites·6 claims
- 1465US9493456B2Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulatorsUNIV MONTREAL·Filed 2015·Granted Nov 15, 2016·1 cites·14 claims
- 1563US11696928B2Compounds and use thereof in the expansion of stem cells and/or progenitor cellsUNIV MONTREAL·Filed 2018·Granted Jul 11, 2023·0 cites·11 claims
- 1663US8148400B2Thiazolyl compounds useful as kinase inhibitorsMARINIER ANNE·Filed 2007·Granted Apr 3, 2012·1 cites·5 claims
- 1762US5945561ARetinoid-like compoundsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Aug 31, 1999·8 cites·8 claims
- 1852US2013165426A1Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulatorsRUEL REJEAN·Filed 2011·Application pending·0 cites
- 1952US2016296507A1Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulatorsUNIV MONTREAL·Filed 2016·Application pending·0 cites
- 2048US7851500B2Aminopyrazole kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Dec 14, 2010·0 cites·9 claims
- 2146US7470713B2Imidazole based kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 30, 2008·0 cites·12 claims
- 2246US2023073512A1Modulators of cullin 3 adaptor kbtbd4 as anti-cancer compoundsUNIV MONTREAL·Filed 2020·Application pending·0 cites
- 2344US7312215B2Benzimidazole C-2 heterocycles as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Dec 25, 2007·0 cites·8 claims
- 2443US9018395B2Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulatorsBOUVIER MICHEL·Filed 2012·Granted Apr 28, 2015·0 cites·12 claims
- 2543US8148361B2Kinase inhibitorsBHIDE RAJEEV S·Filed 2007·Granted Apr 3, 2012·0 cites·5 claims
- 2625US6194601B15,6-dihydronaphthalenyl derivatives having retinoid-like activityBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Feb 27, 2001·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Anne Marinier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →